Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2
Hamad M. Alkahtani, Ashraf N. Abdalla, Ahmad J. Obaidullah, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103461-103461
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)
Parth Bhatia, Vrinda Sharma, Ozair Alam, et al.
European Journal of Medicinal Chemistry (2020) Vol. 204, pp. 112640-112640
Closed Access | Times Cited: 138
Recent Advances on Quinazoline Derivatives: A Potential Bioactive Scaffold in Medicinal Chemistry
Ram Karan, Pooja Agarwal, Mukty Sinha, et al.
ChemEngineering (2021) Vol. 5, Iss. 4, pp. 73-73
Open Access | Times Cited: 64
New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity
Mohamed Sabry, Mariam A. Ghaly, Azza R. Maarouf, et al.
European Journal of Medicinal Chemistry (2022) Vol. 241, pp. 114661-114661
Closed Access | Times Cited: 40
Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors
Bin Zhang, Zhikun Liu, Shengjin Xia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113300-113300
Closed Access | Times Cited: 45
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Ahmed H. Bakheit, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 541-558
Open Access
Synthesis, Biological Evaluation and Molecular Modeling Studies of Quinazolin-4(3h)-One and Benzenesulfonamide Hybrids as Potential Anticancer Agents
Emre Kadir Ayan, Ali Ergüç, Ege Arzuk, et al.
(2025)
Closed Access
Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects
Abdallah Turky, Ashraf H. Bayoumi, Adel Ghiaty, et al.
Bioorganic Chemistry (2020) Vol. 101, pp. 104019-104019
Closed Access | Times Cited: 41
Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights
Mohamed A. Abdelgawad, Arafa Musa, Atiah H. Almalki, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 2325-2337
Open Access | Times Cited: 33
Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies
Abdelrahman Hamdi, Hamed W. El-Shafey, Dina I. A. Othman, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105710-105710
Closed Access | Times Cited: 24
Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study
Abdelrahman Hamdi, Walaa M. El-Husseiny, Dina I. A. Othman, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114827-114827
Closed Access | Times Cited: 22
Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity
Abdulaziz A. Alotaibi, Hanadi H. Asiri, A. F. M. Motiur Rahman, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 5, pp. 101712-101712
Open Access | Times Cited: 13
Antiproliferative Activity, Multikinase Inhibition, Apoptosis- Inducing Effects and Molecular Docking of Novel Isatin–Purine Hybrids
Ashwag S. Alanazi, Tebyan O. Mirgany, Aisha A. Alsfouk, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 610-610
Open Access | Times Cited: 12
Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
Ashwag S. Alanazi, Tebyan O. Mirgany, Nawaf A. Alsaif, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 989-997
Open Access | Times Cited: 10
Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells
Mohamed E. Abdallah, Mahmoud Zaki El-Readi, Mohammad Althubiti, et al.
Molecules (2020) Vol. 25, Iss. 15, pp. 3355-3355
Open Access | Times Cited: 30
Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer
Ashraf N. Abdalla, Amal Qattan, Waleed H. Malki, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4606-4606
Open Access | Times Cited: 27
Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer
Ashraf N. Abdalla, Waleed H. Malki, Amal Qattan, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 334-334
Open Access | Times Cited: 24
Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Nawaf A. Alsaif, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1520-1538
Open Access | Times Cited: 24
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 733-743
Open Access | Times Cited: 26
Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors
Ashraf N. Abdalla, Mohamed E. Abdallah, Akhmed Aslam, et al.
Molecules (2020) Vol. 25, Iss. 9, pp. 2220-2220
Open Access | Times Cited: 26
Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Nawaf A. Alsaif, et al.
Bioorganic Chemistry (2020) Vol. 104, pp. 104345-104345
Closed Access | Times Cited: 26
Discovery and evaluation of cytisine N-isoflavones as novel EGFR/HER2 dual inhibitors
Yanqing Wang, Xiaoying Yin, Ling‐Yan Chen, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105868-105868
Closed Access | Times Cited: 14
Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study
Dina I. A. Othman, Abdelrahman Hamdi, Walaa M. El-Husseiny, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101803-101803
Open Access | Times Cited: 8
Synthesis, molecular modeling simulations and anticancer activity of some new Imidazo[2,1-b]thiazole analogues as EGFR/HER2 and DHFR inhibitors
Esraa A. Moharram, Selwan M. El‐Sayed, Hazem A. Ghabbour, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107538-107538
Closed Access | Times Cited: 2
Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors
Ahmed K.B.A.W. Farouk, Heba Abdelrasheed Allam, Essam Rashwan, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 106099-106099
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top